Trial Profile
Tofacitinib - first-in-man study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Atopic dermatitis; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer